BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 17/11/2017

FDA Announces Draft Guidance for Expedited Review of Regenerative Medicine Therapies for Serious Conditions

The FDA is releasing a draft document outlining its expedited review process for regenerative medicine therapies aimed at treating serious or life-threatening diseases, with the goal of accelerating the development and approval of these treatments.

Source: Federal Register — Food and Drug AdministrationOpen original release →